Rheumatology
News
High-dose teriparatide tops standard dose in boosting BMD in postmenopausal women
A high dose of teriparatide in combination with denosumab increases bone mineral density (BMD) in postmenopausal women with osteoporosis to a...
News
Modifiable risk factors account for many gout cases
A substantial proportion of gout cases are attributable to four modifiable lifestyle risk factors, including BMI and alcohol intake.
News
CDC, SAMHSA commit $1.8 billion to combat opioid crisis
Some of the funds will be used to help improve overdose monitoring.
CE/CME
Click for Credit: Fasting rules for surgery; Biomarkers for PSA vs OA; more
Topics include: Levothyroxine & birth rate • Elderly fall prevention • Fasting rules for surgery • Biomarkers for PsA vs OA • Compression-only...
News
Zoledronic acid reduces symptomatic periodontal disease in patients with osteoporosis
Coupled with good oral hygiene, the investigators suggest zoledronic acid might prevent development of osteonecrosis of the jaw.
News
Zoledronate maintains bone loss after denosumab discontinuation
The results suggest that, after achieving nonosteoporotic BMD with denosumab, a single intravenous infusion of zoledronate given 6 months after...
News
High-dose vitamin D for bone health may do more harm than good
A randomized trial showed an inverse dose-response relationship between high-dose vitamin D supplementation and bone quality in healthy adults.
News
Analysis finds no mortality reductions with osteoporosis drugs
A meta-analysis has found no evidence that osteoporosis drugs are associated with a reduction in mortality.
News
NSAIDs a significant mediator of cardiovascular risk in osteoarthritis
NSAID use could be responsible for a significant proportion of the increased risk of cardiovascular disease associated with osteoarthritis.
CE/CME
Click for Credit: Predicting preeclampsia; MI & stroke post-cancer Dx; more
Topics include: Smoking cessation & RA • Pregnancy loss after stillbirth • Biomarker for dementia? • MI & stroke post-cancer Dx •...